Rob Dee

1.3k total citations · 1 hit paper
11 papers, 961 citations indexed

About

Rob Dee is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Neurology. According to data from OpenAlex, Rob Dee has authored 11 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 4 papers in Hematology and 2 papers in Neurology. Recurrent topics in Rob Dee's work include Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Rob Dee is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Rob Dee collaborates with scholars based in Netherlands, Germany and Austria. Rob Dee's co-authors include C. Ellen van der Schoot, Jacques J. M. van Dongen, Elizabeth Macintyre, Niels Pallisgaard, Peter Hokland, Éric Delabesse, Franz Watzinger, Emmanuel Beillard, J Gäbert and Enrico Gottardi and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Rob Dee

11 papers receiving 948 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

2003 656 citations Emmanuel Beillard, Niels Pallisgaard et al. Leukemia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob Dee Netherlands	9	480	400	233	221	147	11	961
Carin Lassen Sweden	21	570 1.2×	642 1.6×	244 1.0×	297 1.3×	187 1.3×	35	1.3k
A J Carroll United States	17	873 1.8×	703 1.8×	635 2.7×	283 1.3×	75 0.5×	32	1.8k
R. Haas Germany	13	358 0.7×	173 0.4×	175 0.8×	106 0.5×	42 0.3×	48	820
Sarra Ryan United Kingdom	14	307 0.6×	503 1.3×	332 1.4×	372 1.7×	207 1.4×	25	951
Patrick A. Lennon United States	14	188 0.4×	255 0.6×	91 0.4×	293 1.3×	77 0.5×	32	802
Kumi Nakazaki Japan	10	209 0.4×	543 1.4×	47 0.2×	143 0.6×	151 1.0×	34	996
Mark Y. Chiang United States	17	248 0.5×	699 1.7×	231 1.0×	158 0.7×	119 0.8×	32	1.2k
Christian Herens Belgium	16	201 0.4×	275 0.7×	70 0.3×	178 0.8×	67 0.5×	35	877
MI Collector United States	9	478 1.0×	344 0.9×	50 0.2×	282 1.3×	75 0.5×	10	976
D. Soligo Italy	13	449 0.9×	471 1.2×	56 0.2×	257 1.2×	57 0.4×	20	1.1k

Countries citing papers authored by Rob Dee

Since Specialization

Citations

This map shows the geographic impact of Rob Dee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Dee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Dee more than expected).

Fields of papers citing papers by Rob Dee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Dee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Dee. The network helps show where Rob Dee may publish in the future.

Co-authorship network of co-authors of Rob Dee

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Dee. A scholar is included among the top collaborators of Rob Dee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Dee. Rob Dee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Helden, Suzanne F. G. van, Eloise C. Anthony, Rob Dee, & Peter L. Hordijk. (2012). Rho GTPase Expression in Human Myeloid Cells. PLoS ONE. 7(8). e42563–e42563. 24 indexed citations

Nethe, Micha, Eloise C. Anthony, Mar Fernandez‐Borja, et al.. (2010). Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. Journal of Cell Science. 123(11). 1948–1958. 76 indexed citations

Stutterheim, Janine, Lily Zappeij‐Kannegieter, Bilgehan Yalçın, et al.. (2009). Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers. Clinical Chemistry. 55(7). 1316–1326. 55 indexed citations

Stutterheim, Janine, Lily Zappeij‐Kannegieter, Rob Dee, et al.. (2008). PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma. Journal of Clinical Oncology. 26(33). 5443–5449. 71 indexed citations

Haas, Válerie de, et al.. (2007). Changing Gene Expression Patterns during Early Treatment of B-Precursor Acute Lymphoblastic Leukemia May Be Predictive of Relapse.. Blood. 110(11). 232–232. 6 indexed citations

Beillard, Emmanuel, Niels Pallisgaard, Vincent H. J. van der Velden, et al.. (2003). Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia. 17(12). 2474–2486. 656 indexed citations breakdown →

Haas, Válerie de, Rob Dee, O. J. H. M. Verhagen, et al.. (2002). The TEL‐AML1 real‐time quantitative polymerase chain reaction (PCR) might replace the antigen receptor‐based genomic PCR in clinical minimal residual disease studies  in children with acute lymphoblastic leukaemia. British Journal of Haematology. 116(1). 87–93. 17 indexed citations

Haas, Válerie de, Liesbeth E.M. Oosten, Rob Dee, et al.. (2000). Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia. British Journal of Haematology. 111(4). 1080–1086. 13 indexed citations

Haas, Válerie de, Liesbeth E.M. Oosten, Rob Dee, et al.. (2000). Minimal residual disease studies are beneficial in the follow‐up of TEL/AML1 patients with B‐precursor acute lymphoblastic leukaemia. British Journal of Haematology. 111(4). 1080–1086. 3 indexed citations

10.

Berg, Henk van den, C. Ellen van der Schoot, Rob Dee, et al.. (1996). A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid/T lymphoid malignancies.. PubMed. 10(7). 1252–3. 20 indexed citations

11.

Peltenburg, Lucy T.C., et al.. (1993). Downregulation of HLA Class I expression by c-myc in human melanoma is independent of enhancer A. Nucleic Acids Research. 21(5). 1179–1185. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact